SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-035486
Filing Date
2024-02-14
Accepted
2024-02-14 10:55:55
Documents
3
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA SELIGMAN TECHNOLOGY & INFORMATION FUND

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d781241dsc13ga.htm SC 13G/A 62956
2 EX-99.I d781241dex99i.htm EX-99.I 1094
3 EX-99.II d781241dex99ii.htm EX-99.II 4582
  Complete submission text file 0001193125-24-035486.txt   70777
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 24634009
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)